Zander Dani S. 4

What Happened

• Zander Dani S., a member of Medpace Holdings' board of directors, was granted 1,110 derivative shares (reported as an award/acquisition) on 2026-05-15. The Form 4 lists the acquisition price as $0.00 and the transaction is reported as a derivative award (code A). This was an award/compensation event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-15; reported on Form 4 filed 2026-05-18 (Accession 0002029265-26-000002). Price per share: $0.00; total reported cash value: $0 (derivative).
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• Footnote on vesting: the award vests on the earlier of (i) the day before the issuer’s first annual meeting following the grant or (ii) the first anniversary of the grant, subject to continued service on the board (see footnote F1).
• Filing timeliness: filed 2026-05-18 for a 2026-05-15 transaction — reported within the usual two-business-day window (timely).

Context

• This is a derivative award grant (commonly options or restricted stock units) and not an exercise or sale. Such grants are typical director compensation/retention tools and do not by themselves signal a near-term buy or sell of shares. As always, retail investors should view awards as part of broader insider activity and company context rather than a standalone market indicator.